J 2020

European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management

BRODSZKI, Nicholas, Ashley FRAZER-ABEL, Anete S. GRUMACH, Anete S. KIRSCHFINK, Jiří LITZMAN et. al.

Základní údaje

Originální název

European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management

Autoři

BRODSZKI, Nicholas (752 Švédsko), Ashley FRAZER-ABEL (840 Spojené státy), Anete S. GRUMACH (76 Brazílie), Anete S. KIRSCHFINK (276 Německo), Jiří LITZMAN (203 Česká republika, domácí), Elena PEREZ (840 Spojené státy), Mikko R. J. SEPPANEN (246 Finsko), Kathleen E. SULLIVAN (840 Spojené státy) a Stephen JOLLES (826 Velká Británie a Severní Irsko, garant)

Vydání

Journal of Clinical Immunology, New York, Springer, 2020, 0271-9142

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 8.317

Kód RIV

RIV/00216224:14110/20:00116025

Organizační jednotka

Lékařská fakulta

UT WoS

000516182000001

Klíčová slova anglicky

Complement; complement deficiencies; classical pathway; alternative pathway; mannan-binding lectin

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 17. 7. 2020 09:41, Mgr. Tereza Miškechová

Anotace

V originále

This guideline aims to describe the complement system and the functions of the constituent pathways, with particular focus on primary immunodeficiencies (PIDs) and their diagnosis and management. The complement system is a crucial part of the innate immune system, with multiple membrane-bound and soluble components. There are three distinct enzymatic cascade pathways within the complement system, the classical, alternative and lectin pathways, which converge with the cleavage of central C3. Complement deficiencies account for similar to 5% of PIDs. The clinical consequences of inherited defects in the complement system are protean and include increased susceptibility to infection, autoimmune diseases (e.g., systemic lupus erythematosus), age-related macular degeneration, renal disorders (e.g., atypical hemolytic uremic syndrome) and angioedema. Modern complement analysis allows an in-depth insight into the functional and molecular basis of nearly all complement deficiencies. However, therapeutic options remain relatively limited for the majority of complement deficiencies with the exception of hereditary angioedema and inhibition of an overactivated complement system in regulation defects. Current management strategies for complement disorders associated with infection include education, family testing, vaccinations, antibiotics and emergency planning.